Two Sigma Advisers’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Buy |
140,300
+79,300
| +130% | +$162K | ﹤0.01% | 1979 |
|
|
2025
Q1 | $81.1K | Buy |
61,000
+31,800
| +109% | +$42.3K | ﹤0.01% | 2264 |
|
|
2024
Q4 | $77.4K | Sell |
29,200
-58,300
| -67% | -$154K | ﹤0.01% | 2249 |
|
|
2024
Q3 | $159K | Sell |
87,500
-44,000
| -33% | -$80.1K | ﹤0.01% | 2114 |
|
|
2024
Q2 | $218K | Sell |
131,500
-30,500
| -19% | -$50.6K | ﹤0.01% | 2180 |
|
|
2024
Q1 | $371K | Sell |
162,000
-6,700
| -4% | -$15.3K | ﹤0.01% | 1993 |
|
|
2023
Q4 | $334K | Sell |
168,700
-59,500
| -26% | -$118K | ﹤0.01% | 2072 |
|
|
2023
Q3 | $297K | Sell |
228,200
-233,000
| -51% | -$303K | ﹤0.01% | 1982 |
|
|
2023
Q2 | $747K | Buy |
461,200
+87,200
| +23% | +$141K | ﹤0.01% | 1654 |
|
|
2023
Q1 | $797K | Buy |
374,000
+122,500
| +49% | +$261K | ﹤0.01% | 1745 |
|
|
2022
Q4 | $931K | Buy |
251,500
+78,200
| +45% | +$289K | ﹤0.01% | 1598 |
|
|
2022
Q3 | $129K | Buy |
173,300
+117,400
| +210% | +$87.4K | ﹤0.01% | 2275 |
|
|
2022
Q2 | $43K | Sell |
55,900
-75,800
| -58% | -$58.3K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $119K | Buy |
+131,700
| New | +$119K | ﹤0.01% | 2480 |
|
|
2021
Q4 | – | Sell |
-12,700
| Closed | -$106K | – | 2770 |
|
|
2021
Q3 | $106K | Buy |
+12,700
| New | +$106K | ﹤0.01% | 2320 |
|
|
2020
Q3 | – | Sell |
-13,600
| Closed | -$83K | – | 2593 |
|
|
2020
Q2 | $83K | Buy |
+13,600
| New | +$83K | ﹤0.01% | 2382 |
|